model_id,passage_range,treatment_name,treatment_type,treatment_dose,administration_route,treatment_schedule,treatment_length,treatment_response,response_classification,platform_id,provider
HBCx-118,2.3,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,3,Olaparib,treatment,100 mg/kg,per os,5x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,3,Niraparib,treatment,50 mg/kg,per os,5x/w,53 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,3,AZD5363,treatment,50x2 mg/kg,per os,"5x/w, BID",53 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,3,AZD5363 + Fulvestrant,treatment,50x2 mg/kg + 50 mg/kg,per os + subcutaneous,"5x/w, BID + once a week",53 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,3,Everolimus,treatment,2.5 mg/kg,per os,3x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,2,Palbociclib,treatment,75 mg/kg,per os,5x/w,67 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-118,2,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,67 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-124,10,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,67 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-124,10,Palbociclib,treatment,75 mg/kg,per os,5x/w,67 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-124,10,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,67 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-124,18,AZD4547 + Fulvestrant,treatment,12.5 mg/g + 50 mg/kg,per os + subcutaneous,5x/w + once a week,60 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-124,18,Everolimus + Fulvestrant,treatment,2.5 mg/kg + 50 mg/kg,per os + subcutaneous,3x/w + once a week,60 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,10,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,10,Palbociclib,treatment,75 mg/kg,per os,5x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,10,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,10,Erdafitinib,treatment,12.5 mg/kg,per os,5x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,10,Erdatitinib + Fulvestrant,treatment,12.5 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,24,Paclitaxel,treatment,20 mg/kg,Intraperitoneal,1x/w,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-131,24,Enhertu,treatment,10 mg/kg,Intravenous,one injection,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-134,6,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,36 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-134,6,Palbociclib,treatment,75 mg/kg,per os,5x/w,36 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-134,6,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,36 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-134,10,BYL719,treatment,35 mg/kg,per os,5x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-134,10,BYL719 + Fulvestrant,treatment,35 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,Palbociclib,treatment,75 mg/kg,per os,5x/w,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,AZD4547,treatment,12.5 mg/kg,per os,5x/w,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,AZD4547 + Fulvestrant,treatment,12.5 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,4,Erdafitinib,treatment,12.5 mg/kg,per os,5x/w,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-137,14,Everolimus + Fulvestrant,treatment,2.5 mg/kg + 50 mg/kg,per os + subcutaneous,3x/w + once a week,25 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,6,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,6,Palbociclib,treatment,75 mg/kg,per os,5x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,6,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,6,BYL719,treatment,35 mg/kg,per os,5x/w,53 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,6,BYL719 + Fulvestrant,treatment,35 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-139,10,Everolimus + Fulvestrant,treatment,2.5 mg/kg + 25 mg/kg,per os + subcutaneous,3x/w + once a week,46 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,62 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,Palbociclib,treatment,75 mg/kg,per os,5x/w,62 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,62 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,AZD5363,treatment,50x2 mg/kg,per os,"5x/w, BID",62 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,AZD5363 + Fulvestrant,treatment,50x2 mg/kg + 50 mg/kg,per os + subcutaneous,"5x/w, BID + once a week",62 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-142,4,Everolimus,treatment,2.5 mg/kg,per os,3x/w,62 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-150,3,AZD4547,treatment,12.5 mg/kg,per os,5x/w,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-176,4,Palbociclib,treatment,75 mg/kg,per os,5x/w,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-176,4,Selumetinib,treatment,50 mg/kg,per os,5x/w,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-176,4,Trametinib,treatment,1 mg/kg,per os,5x/w,25 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,3,Fulvestrant,treatment,50 mg/kg,subcutaneous,once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,3,Palbociclib,treatment,75 mg/kg,per os,5x/w,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,3,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,3,Everolimus + Fulvestrant,treatment,2.5 mg/kg + 50 mg/kg,per os + subcutaneous,3x/w + once a week,53 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,3,BYL719 + Fulvestrant,treatment,35 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,53 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,9,Enhertu,treatment,4 mg/kg,intravenous,one injection,54 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-180,9,Enhertu,treatment,10 mg/kg,intravenous,one injection,54 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-202,1,Palbociclib,treatment,75 mg/kg,per os,5x/w,32 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-202,1,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,32 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-202,11,Paclitaxel,treatment,15 mg/kg,Intraperitoneal,once a week,45 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-227,2,Palbociclib + Fulvestrant,treatment,75 mg/kg + 50 mg/kg,per os + subcutaneous,5x/w + once a week,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-227,2,Everolimus + Fulvestrant,treatment,2.5 mg/kg + 50 mg/kg,per os + subcutaneous,3x/w + once a week,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-217,4,Talazoparib ,treatment,"2x0,17 mg/kg",per os,"4x/w, BID",22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-210,4,Talazoparib ,treatment,"2x0,17 mg/kg",per os,"4x/w, BID",43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Gedatolisib,treatment,10 mg/kg,Intraperitoneal,5x/w,43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-206,3,Talazoparib ,treatment,"2x0,17 mg/kg",per os,"4x/w, BID",43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",22 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,22 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Gedatolisib,treatment,10 mg/kg,Intraperitoneal,5x/w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Talazoparib ,treatment,"0,2 mg/kg",per os,3x/w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-200,3,Olaparib,treatment,2x50 mg/kg,per os,"5x/w, BID",15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,2,Talazoparib ,treatment,"2x0,17 mg/kg",per os,5x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,12,Olaparib,treatment,75 mg/kg,per os,5x/w,40 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-209,12,Talazoparib ,treatment,"2x0,17 mg/kg",per os,4x/w,40 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,Paclitaxel ,treatment,25 mg/kg,Intraperitoneal,1x/w,15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,Carboplatine ,treatment,90 mg/kg,Intraperitoneal,1x/3w,22 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-185,17,Talazoparib ,treatment,"2x0,17 mg/kg",per os,"5x/w, BID",15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-31,2,Everolimus,treatment,2.5 mg/kg,per os,3x/w,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-31,3,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,25 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-31,3,Xeloda ,treatment,270x2 mg/kg,per os,"5x/w, BID",25 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-31,5,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,49 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-31,5,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,49 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-149,6,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,29 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-149,24,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,18 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-149,24,Olaparib,treatment,2x50 mg/kg,per os,"5x/w, BID",18 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-149,27,Olaparib,treatment,75 mg/kg,per os,5x/w,18 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,11,CPT11,treatment,40 mg/kg,Intraperitoneal,1x/w,39 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,14,Olaparib,treatment,100 mg/kg,per os,5x/w,29 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,27 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,27 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,Xeloda ,treatment,540 mg/kg,per os,5x/w,27 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,27 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,27 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-151,3,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",27 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,16,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,37 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,16,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,37 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,16,Paclitaxel,treatment,20 mg/kg,Intraperitoneal,1x/w,37 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,16,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",37 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,18,Olaparib,treatment,100 mg/kg,per os,5x/w,31 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,28,Paclitaxel,treatment,25 mg/kg,Intraperitoneal,1x/w,29 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-92,28,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,29 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,29,Paclitaxel,treatment,25 mg/kg,Intraperitoneal,1x/w,29 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,29,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,29,Olaparib,treatment,100 mg/kg,per os,5x/w,15 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,10,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,29 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,8,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",38 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,7,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,39 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,3,Olaparib,treatment,100 mg/kg,per os,5x/w,24 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,3,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,3,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",43 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-106,3,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,43 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,"15,12,30",Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID","32,24,41 days",response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,14.49,Paclitaxel,treatment,25 mg/kg,Intraperitoneal,1x/w,"36,39 days",progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,46,Olaparib,treatment,100 mg/kg,per os,5x/w,31 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,40.3,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,"27,41 days",progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,30,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,41 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,30,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,41 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,15,Everolimus,treatment,2.5 mg/kg,per os,3x/w,47 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-39,4,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,32 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,60,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,23 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,56.22,Olaparib,treatment,100 mg/kg,per os,5x/w,"37,46 days",progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,45,Everolimus,treatment,2.5 mg/kg,per os,3x/w,32 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,45,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,32 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,12,Paclitaxel,treatment,20 mg/kg,Intraperitoneal,1x/w,50 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,5,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",80 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,8,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,75 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-2,4,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,33 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,55,Olaparib,treatment,100 mg/kg,per os,5x/w,18 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,53,Olaparib,treatment,75 mg/kg,per os,5x/w,25 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,30,Paclitaxel,treatment,25 mg/kg,Intraperitoneal,1x/w,22 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,22,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,43 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,22.17,Paclitaxel,treatment,20 mg/kg,Intraperitoneal,1x/w,"46,25 days",progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,15.14,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,"29,32 days",response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,14,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,32 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,27,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,28 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-8,45,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",49 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,66,Paclitaxel,treatment,25 mg/kg,Intraperitoneal,1x/w,24 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,53,CPT11,treatment,50 mg/kg,Intraperitoneal,1x/w,22 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,47,Olaparib,treatment,100 mg/kg,per os,5x/w,24 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,4,Adriamycine + Cyclophosphamide,treatment, 2 mg/kg +  100 mg/kg,Intraperitoneal,1x/3w,82 days,stable disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,4,Docetaxel,treatment,20 mg/kg,Intraperitoneal,1x/3w,82 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,4,Cisplatin,treatment,6 mg/kg,Intraperitoneal,1x/3w,82 days,progressive disease,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
HBCx-30,4,Xeloda ,treatment,2x270 mg/kg,per os,"5x/w, BID",82 days,response,"Responder: -50<% of change from baseline ; TGI>50% / Stable disease: -50<% of change
 from baseline<35 /Non responder: % of change from baseline>35 ; TGI<50%",drugdosing,Curie-BC
EMC0052PM,,Dactolisib,treatment,40.0 mg/kg,oral gavage,,,stable disease,modified RECIST criteria,drugdosing,TRACE
EMC0052PM,,Trabectedin,treatment,0.15 mg/kg,intravenous,,,stable disease,modified RECIST criteria,drugdosing,TRACE
EMC0049PM,,Dactolisib,treatment,40.0 mg/kg,oral gavage,,,progressive disease,modified RECIST criteria,drugdosing,TRACE
EMC0049PM,,Trabectedin,treatment,0.15 mg/kg,intravenous,,,progressive disease,modified RECIST criteria,drugdosing,TRACE
EMC0047PR,,Dactolisib,treatment,40.0 mg/kg,oral gavage,,,partial response,modified RECIST criteria,drugdosing,TRACE
EMC0047PR,,Trabectedin,treatment,0.15 mg/kg,intravenous,,,partial response,modified RECIST criteria,drugdosing,TRACE
EMC0078TM,,Dactolisib,treatment,40.0 mg/kg,oral gavage,,,partial response,modified RECIST criteria,drugdosing,TRACE
EMC0078TM,,Trabectedin,treatment,0.15 mg/kg,intravenous,,,partial response,modified RECIST criteria,drugdosing,TRACE
HCI-001,,paclitaxel,treatment,10 mg/kg,intravenous,Q3D,,progressive disease,,drugdosing,HCI-BCM
HCI-001,,cyclophosphamide + doxorubicin,treatment,100 mg/kg,intraperitoneal,weekly,,stable disease,,drugdosing,HCI-BCM
HCI-001,,doxorubicin,treatment,10 mg/kg,intravenous,weekly,,stable disease,,drugdosing,HCI-BCM
HCI-002,,doxorubicin + cyclophosphamide,treatment,1 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,HCI-BCM
HCI-002,,doxorubicin,treatment,10 mg/kg,intravenous,weekly,,stable disease,,drugdosing,HCI-BCM
HCI-003,,tamoxifen,treatment,1 mg/kg,,daily,,stable disease,,drugdosing,HCI-BCM
HCI-005,,trastuzumab,treatment,2 mg/kg,,weekly,,progressive disease,,drugdosing,HCI-BCM
HCI-005,,paclitaxel,treatment,10 mg/kg,intravenous,Q3D,,partial response,,drugdosing,HCI-BCM
HCI-007,,paclitaxel,treatment,10 mg/kg,intravenous,Q3D,,progressive disease,,drugdosing,HCI-BCM
HCI-009,,doxorubicin,treatment,10 mg/kg,intraperitoneal,weekly,,stable disease,,drugdosing,HCI-BCM
LCF4,23,Cisplatin,treatment,6.0 mg/kg,intraperitoneal,D1,31 days,partial response,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF9,5,Cisplatin,treatment,6.0 mg/kg,intraperitoneal,D1,43 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF9,15,Cisplatin,treatment,1.0 mg/kg,intraperitoneal,D1-D3-D5-D12-D15,37 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF15,5,Docetaxel,treatment,20.0 mg/kg,intraperitoneal,D1-D21,26 days,partial response,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF15,8,Docetaxel,treatment,20.0 mg/kg,intraperitoneal,D1-D21,32 days,partial response,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF15,8,Cisplatin,treatment,6.0 mg/kg,intraperitoneal,D1-D21,32 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF15,29,Cisplatin,treatment,6.0 mg/kg,intraperitoneal,D1,29 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF15,29,Cisplatin + Paclitaxel,treatment,"4.0 mg/kg, 20.0 mg/kg",intraperitoneal,D1-D21,49 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF26,6,Cisplatin,treatment,1.0 mg/kg,intraperitoneal,D1-D3-D5-D12-D15,32 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF26,15,Paclitaxel + Cisplatin,treatment,"20 mg/kg, 4 mg/kg",intraperitoneal,D1-D21,30 days,partial response,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF26,19,Paclitaxel + Cisplatin,treatment,"20 mg/kg, 4 mg/kg",intraperitoneal,D1-D21,32 days,partial response,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF26,19,Pemetrexed + Cisplatin,treatment,"100 mg/kg, 4 mg/kg",intraperitoneal,D1-D21 + D1-D7-D14-D21-D28,32 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
LCF26,19,Cisplatin,treatment,6.0 mg/kg,intraperitoneal,D1-D21,29 days,stable disease,TGI (tumor growth inhibition),drugdosing,Curie-LC
NIBRX-1536,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,5FU,treatment,75 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,5FU,treatment,75 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,5FU,treatment,75 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,5FU,treatment,75 mg/kg,intravenous,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5405,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3671,,5FU,treatment,75 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,abraxane,treatment,20 mg/kg,intravenous,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3268,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2026,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3028,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3052,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3800,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4015,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4927,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4377,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4316,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2283,,abraxane + gemcitabine,treatment,"25, 50 mg/kg","intravenous, intraperitoneal","day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,BGJ398,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,BGJ398,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,BGJ398,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5975,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,BGJ398,treatment,35 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-5502,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BGJ398,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,BGJ398,treatment,35 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-1383,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,binimetinib,treatment,30 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,binimetinib,treatment,30 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,binimetinib,treatment,30 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,binimetinib,treatment,30 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4567,,binimetinib,treatment,30 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-6047,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3671,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,binimetinib,treatment,30 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,binimetinib,treatment,30 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,binimetinib,treatment,30 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,binimetinib,treatment,30 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3029,,binimetinib,treatment,30 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2017,,binimetinib,treatment,30 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3127,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,binimetinib,treatment,10 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,binimetinib,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,binimetinib,treatment,50 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,binimetinib,treatment,50 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,binimetinib,treatment,50 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1199,,binimetinib,treatment,50 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4676,,binimetinib,treatment,50 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3800,,binimetinib,treatment,50 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5205,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-1362,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1317,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-2428,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3038,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-4018,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2283,,binimetinib-3.5mpk,treatment,3.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3077,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3450,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5355,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5975,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,BKM120,treatment,35 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1441,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,BKM120,treatment,35 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3880,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,BKM120,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,BKM120,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,BKM120,treatment,35 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,BKM120,treatment,35 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1683,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1442,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5205,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2339,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1199,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1317,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2428,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3990,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4927,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4676,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3800,,BKM120 + binimetinib,treatment,"30, 3.5 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2700,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2163,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4644,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2838,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,BKM120 + encorafenib,treatment,"30, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2428,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3800,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3898,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4649,,BKM120 + LDE225,treatment,"30, 60 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BKM120 + LJC049,treatment,"30, 30 mg/kg","oral, subcutaneous","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1298,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,BYL719,treatment,50 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3077,,BYL719,treatment,50 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4347,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,BYL719,treatment,50 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,BYL719,treatment,50 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5205,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,BYL719,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,BYL719,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5494,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2239,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719 + binimetinib,treatment,"25, 10 mg/kg","oral, intraperitoneal","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2239,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719 + cetuximab,treatment,"25, 20 mg/kg","oral, intraperitoneal","daily, every two weeks",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5494,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2239,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719 + cetuximab + encorafenib,treatment,"25, 20, 20 mg/kg","oral, intraperitoneal, oral","daily, every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719 + encorafenib,treatment,"25, 20 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3077,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3697,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3873,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4888,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5355,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5975,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4347,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4567,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,BYL719 + LEE011,treatment,"25, 250 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2082,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,BYL719 + LGH447,treatment,"20, 50 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2780,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4949,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3450,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4567,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5438,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1855,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1156,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1683,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5205,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4215,,BYL719 + LJM716,treatment,"30, 25 mg/kg","oral, intraperitoneal","daily, every other day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3792,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1303,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1500,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-5446,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3671,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2082,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,cetuximab,treatment,20 mg/kg,intraperitoneal,twice weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-0933,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5494,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2182,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2239,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4087,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,cetuximab + encorafenib,treatment,"20, 20 mg/kg","intraperitoneal, oral","every two weeks, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,CGM097,treatment,100 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1499,,CGM097,treatment,100 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3127,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,CGM097,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,CGM097,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,CKX620,treatment,30 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3224,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,CKX620,treatment,30 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,CKX620,treatment,30 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,CKX620,treatment,30 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1683,,CKX620,treatment,30 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1835,,CKX620,treatment,30 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,CKX620,treatment,30 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1993,,CKX620,treatment,30 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-1298,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,CLR457,treatment,20 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3697,,CLR457,treatment,20 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3873,,CLR457,treatment,20 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4824,,CLR457,treatment,20 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4949,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,CLR457,treatment,20 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,CLR457,treatment,20 mg/kg,oral,twice per day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5405,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,CLR457,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,CLR457,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2163,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,dacarbazine,treatment,80 mg/kg,intraperitoneal,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,encorafenib,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,encorafenib,treatment,20 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,encorafenib,treatment,20 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,encorafenib,treatment,20 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3676,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3503,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,encorafenib + binimetinib,treatment,"20, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,erlotinib,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,erlotinib,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,erlotinib,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,erlotinib,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,erlotinib,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,erlotinib,treatment,80 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1683,,erlotinib,treatment,80 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,erlotinib,treatment,80 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5205,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2220,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,figitumumab,treatment,20 mg/kg,intraperitoneal,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,figitumumab + binimetinib,treatment,"20, 3.5 mg/kg","intraperitoneal, oral","weekly, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-1362,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4676,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4015,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1289,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2026,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3990,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2283,,gemcitabine,treatment,50 mg/kg,intraperitoneal,"day 1,4,7 every other week",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,HDM201,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,HDM201,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,HDM201,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,HDM201,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,HDM201,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,HDM201,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,HDM201,treatment,50 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5205,,HDM201,treatment,70 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-1362,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,HDM201,treatment,70 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,HDM201,treatment,70 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,HSP990,treatment,15 mg/kg,oral,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,HSP990,treatment,15 mg/kg,oral,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,HSP990,treatment,15 mg/kg,oral,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,HSP990,treatment,15 mg/kg,oral,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,HSP990,treatment,15 mg/kg,oral,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,HSP990,treatment,15 mg/kg,oral,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,HSP990,treatment,15 mg/kg,oral,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1683,,HSP990,treatment,15 mg/kg,oral,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1725,,HSP990,treatment,15 mg/kg,oral,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,HSP990,treatment,15 mg/kg,oral,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-2082,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,INC280,treatment,10 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,INC424,treatment,90 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,INC424,treatment,90 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4927,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,INC424 + binimetinib,treatment,"60, 3.5 mg/kg","oral, oral","twice per day, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2042,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1835,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3029,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1870,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1658,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,complete response,,drugdosing,DFCI-CPDM
NIBRX-1683,,LCL161 + paclitaxel,treatment,"100, 12.5 mg/kg","oral, intravenous","weekly, weekly",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2613,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LDE225,treatment,80 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,LDE225,treatment,80 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LDK378,treatment,50 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,LDK378,treatment,50 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,LEE011,treatment,250 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4824,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,LEE011,treatment,250 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,LEE011,treatment,250 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-1835,,LEE011,treatment,250 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2613,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1959,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,LEE011,treatment,250 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,LEE011,treatment,250 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4927,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,LEE011,treatment,250 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2163,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2921,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1906,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3211,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2838,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2723,,LEE011 + binimetinib,treatment,"250, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2602,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-2163,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,LEE011 + encorafenib,treatment,"250, 20 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-1828,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-1298,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3450,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3873,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5355,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4347,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4824,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5502,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2195,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5975,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-4567,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LEE011 + everolimus,treatment,"250, 10 mg/kg","oral, oral","daily, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LFA102,treatment,20 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1256,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1210,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0992,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2514,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1333,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5254,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5421,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5536,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2761,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1234,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5238,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3684,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1979,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-20689,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1795,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-20810,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2017,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5267,,LFW527 + binimetinib,treatment,"12.5, 10 mg/kg","oral, oral","daily, twice per day",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-21617,,LFW527 + binimetinib,treatment,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1349,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2127,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3453,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-4567,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5541,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LFW527 + everolimus,treatment,"15, 10 mg/kg","oral, oral","twice per day, daily",,partial response,,drugdosing,DFCI-CPDM
NIBRX-2082,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,LGH447,treatment,100 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,LGH447,treatment,100 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,LGH447,treatment,100 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2613,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-2838,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,LGW813,treatment,1.8 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,LJC049,treatment,30 mg/kg,subcutaneous,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,partial response,,drugdosing,DFCI-CPDM
NIBRX-4949,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LJM716,treatment,25 mg/kg,intraperitoneal,every other day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-3450,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,partial response,,drugdosing,DFCI-CPDM
NIBRX-5249,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,complete response,,drugdosing,DFCI-CPDM
NIBRX-5502,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LJM716 + trastuzumab,treatment,"25, 15 mg/kg","intraperitoneal, intravenous","every other day, weekly",,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,LKA136,treatment,5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2220,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,LKA136,treatment,5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,LKA136,treatment,5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,LKA136,treatment,5 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-4377,,LKA136,treatment,5 mg/kg,oral,twice per day,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2283,,LKA136,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,partial response,,drugdosing,DFCI-CPDM
NIBRX-5249,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2640,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,complete response,,drugdosing,DFCI-CPDM
NIBRX-4567,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,LLM871,treatment,15 mg/kg,intravenous,every two weeks,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2780,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3873,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,partial response,,drugdosing,DFCI-CPDM
NIBRX-3298,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-5975,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-4567,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-3201,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,paclitaxel,treatment,12.5 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,tamoxifen,treatment,60 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,TAS266,treatment,40 mg/kg,intravenous,weekly,,complete response,,drugdosing,DFCI-CPDM
NIBRX-4849,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2613,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,TAS266,treatment,40 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,TAS266,treatment,40 mg/kg,intravenous,weekly,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,TAS266,treatment,40 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2220,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,trametinib,treatment,2 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,trametinib,treatment,2 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,trametinib,treatment,2 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,trametinib,treatment,2 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,trametinib,treatment,2 mg/kg,oral,daily,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,trametinib,treatment,2 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1199,,trametinib,treatment,2 mg/kg,oral,daily,,partial response,,drugdosing,DFCI-CPDM
NIBRX-1289,,trametinib,treatment,2 mg/kg,oral,daily,,complete response,,drugdosing,DFCI-CPDM
NIBRX-2283,,trametinib,treatment,2 mg/kg,oral,daily,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,trastuzumab,treatment,15 mg/kg,intravenous,weekly,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1383,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2780,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1004,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1008,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1298,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1371,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1407,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1468,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1600,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1631,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1828,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1921,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2344,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2487,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1286,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1832,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2353,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2524,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2640,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3450,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3873,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5502,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3078,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2195,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3077,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3298,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3697,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4888,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5355,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5975,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-6047,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4347,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4567,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4824,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4949,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5249,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3201,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1916,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3468,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3792,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-0933,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1119,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1173,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1536,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3093,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1027,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1055,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1167,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1303,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1500,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2145,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2374,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2483,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1270,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3267,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2659,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1538,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5438,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2822,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2861,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3205,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1329,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1441,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2403,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5254,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5405,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5494,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5495,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2182,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2484,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1479,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2846,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2239,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3224,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1290,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1855,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1443,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5578,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5446,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4087,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2538,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2573,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3671,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2082,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1156,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1172,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1499,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1658,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1787,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1834,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1934,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1980,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1993,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2042,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2088,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1323,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1442,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1683,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1725,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1835,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1586,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3029,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1870,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3237,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2017,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3843,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4819,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1823,,untreated,control,,,,,partial response,,drugdosing,DFCI-CPDM
NIBRX-2613,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1317,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2043,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2220,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2997,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,untreated,control,,,,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,untreated,control,,,,,partial response,,drugdosing,DFCI-CPDM
NIBRX-2613,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2602,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2700,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3127,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3880,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4426,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4455,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4668,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4849,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2163,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3486,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4339,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3746,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3676,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2921,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4832,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4644,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3503,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4538,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1655,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3773,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2306,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2753,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1906,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4157,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4530,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3211,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2838,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5189,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2723,,WNT974,treatment,5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-5205,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1289,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1362,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2026,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2470,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3268,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1948,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2220,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2428,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2564,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2684,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-1199,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4316,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3800,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4215,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4226,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4676,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2081,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3052,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3782,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2339,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3028,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-4377,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,stable disease,,drugdosing,DFCI-CPDM
NIBRX-3816,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3846,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3898,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3947,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3990,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4015,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4018,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-3038,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4378,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4649,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-4927,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
NIBRX-2283,,WNT974,treatment,2.5 mg/kg,oral,twice per day,,progressive disease,,drugdosing,DFCI-CPDM
J000077451,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000077451,,Docetaxel,treatment,6.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077451,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,Avastin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,Valproic acid,treatment,200.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,Rapamycin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,Avastin + Rapamycin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000077712,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000079689,,Topotecan,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
J000079689,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000079689,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000079689,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000079689,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000080739,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000080739,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000080739,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000080739,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000080739,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000095635,,CMC + D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000095635,,CMC + D5W,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000095635,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000095635,,Docetaxel,treatment,6.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000095635,,Trametinib,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000095635,,Docetaxel + Trametinib,treatment,6.0 mg/kg,,,,partial response,,drugdosing,JAX
J000095635,,Docetaxel + Trametinib,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
J000096652,,D5W + CMC,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000096652,,D5W + CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000096652,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000096652,,Docetaxel,treatment,6.0 mg/kg,,,,partial response,,drugdosing,JAX
J000096652,,Trametinib,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000096652,,Docetaxel + Trametinib,treatment,6.0 mg/kg,,,,partial response,,drugdosing,JAX
J000096652,,Docetaxel + Trametinib,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
J000099327,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000099327,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000099327,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000099327,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000099327,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,Topotecan,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,Carboplatin,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100556,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000100646,,Cisplatin + Gemcitabine,treatment,150.0 mg/kg,,,,partial response,,drugdosing,JAX
J000100646,,Cisplatin + Gemcitabine,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
J000100646,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000100646,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000100646,,Gemcitabine,treatment,150.0 mg/kg,,,,partial response,,drugdosing,JAX
J000100672,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100672,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100674,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000100674,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100674,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100674,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100674,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100675,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100675,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000100675,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
J000100675,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000100675,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000101173,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000101173,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000101173,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000101173,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000101173,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102184,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000102184,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000102184,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102184,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102184,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,Oxaliplatin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102630,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,Oxaliplatin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000102680,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103634,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103634,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000103634,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103634,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103634,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103917,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103917,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000103917,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000103917,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
J000103917,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104256,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000104256,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104256,,Gemcitabine,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104256,,Cisplatin + Gemcitabine,treatment,100.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000104256,,Cisplatin + Gemcitabine,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
J000104518,,Gemcitabine,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104518,,Cisplatin + Gemcitabine,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104518,,Cisplatin + Gemcitabine,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104518,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000104518,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000105006,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000105006,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000105006,,Gemcitabine,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000105006,,Cisplatin + Gemcitabine,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000105006,,Cisplatin + Gemcitabine,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000106560,,CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
J000106560,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000106560,,Dabrafenib,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
J000106560,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00020,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00020,,Paclitaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00024,,Paclitaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00024,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00024,,Carboplatin,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00024,,Carboplatin,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00024,,Saline,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00025,,Gemcitabine,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00025,,Paclitaxel,treatment,15.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00025,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00025,,Carboplatin,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00090,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00090,,Cyclophosphamide,treatment,40.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00090,,Cisplatin,treatment,2.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00090,,Docetaxel,treatment,15.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00090,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00091,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00091,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00091,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00091,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00091,,Docetaxel,treatment,15.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00096,,Docetaxel,treatment,15.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00096,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00096,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00096,,Doxorubicin,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00096,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00097,,Docetaxel,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00097,,Cyclophosphamide,treatment,40.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00097,,Cisplatin,treatment,2.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00097,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00097,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00097,,Doxorubicin,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00098,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00098,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00098,,Cyclophosphamide,treatment,40.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00098,,Docetaxel,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00098,,Cisplatin,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00099,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00099,,Cisplatin,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00099,,Doxorubicin,treatment,3.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00099,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00099,,Docetaxel,treatment,20.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00103,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00103,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00103,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00103,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00103,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00107,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00107,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00107,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00107,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00107,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00113,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00113,,Docetaxel,treatment,6.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00113,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00113,,Cyclophosphamide,treatment,40.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00113,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00134,,Oxaliplatin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00134,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00134,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00134,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00134,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00164,,Oxaliplatin,treatment,5.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00164,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00164,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00164,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00164,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,Oxaliplatin + 5-FU,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,Oxaliplatin,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00170,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00176,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00176,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00176,,5-FU,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00176,,Gemcitabine,treatment,150.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00185,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00185,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00185,,Docetaxel,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00185,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00186,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00186,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00186,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00186,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00188,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00188,,Docetaxel,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00188,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00188,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00192,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00192,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00192,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00192,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00193,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00193,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00193,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00194,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00194,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00194,,Etoposide,treatment,15.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00194,,Topotecan,treatment,2.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00194,,Cisplatin + Etoposide,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00194,,Cisplatin + Etoposide,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00196,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00196,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00196,,Docetaxel,treatment,15.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00199,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00199,,Erlotinib,treatment,50.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00199,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00199,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,Docetaxel,treatment,15.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,Trametinib,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,D5W + CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,D5W + CMC,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,Docetaxel,treatment,8.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00203,,Trametinib,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00203,,Docetaxel + Trametinib,treatment,8.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00203,,Docetaxel + Trametinib,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00204,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00204,,CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00206,,CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00206,,Crizotinib,treatment,50.0 mg/kg,,,,complete response,,drugdosing,JAX
TM00208,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00208,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00208,,Docetaxel,treatment,15.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00212,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00212,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00212,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00212,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00213,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00213,,Trametinib,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00213,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00213,,Docetaxel,treatment,15.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00214,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00214,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00214,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00219,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00219,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00219,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00219,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00222,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00222,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00222,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00222,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00226,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00226,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00226,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00226,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00231,,Cisplatin,treatment,1.5 mg/kg,,,,stable disease,,drugdosing,JAX
TM00231,,Docetaxel,treatment,20.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00231,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00231,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00233,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00233,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00233,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00233,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00246,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00246,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00246,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00253,,Erlotinib,treatment,50.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00253,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00253,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00253,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00256,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00256,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00256,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00298,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00298,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00298,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00302,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00302,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00302,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00302,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00324,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00324,,Docetaxel,treatment,6.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00324,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00335,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00335,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00335,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00339,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00339,,CMC,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00339,,Dabrafenib,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00339,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00355,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00355,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00355,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00356,,Trametinib,treatment,3.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00356,,Docetaxel,treatment,15.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00356,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00356,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00385,,5-FU,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00385,,Saline,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00385,,5-FU,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00385,,5-FU,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00386,,Tamoxifen,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00387,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00387,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00387,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00387,,Doxorubicin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00702,,CMC,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00702,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00702,,Dabrafenib,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00702,,Temozolomide,treatment,30.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00784,,Erlotinib,treatment,50.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00784,,Docetaxel,treatment,15.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00784,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00784,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00832,,DMSO,treatment,10.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00832,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM00832,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00877,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00877,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00877,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM00943,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM00943,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00943,,Dabrafenib,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00943,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00999,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00999,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00999,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00999,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM00999,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01029,,Gemcitabine,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01029,,Cisplatin + Gemcitabine,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01029,,Cisplatin + Gemcitabine,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01029,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01029,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01039,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01039,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01039,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01039,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,Oxaliplatin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,Oxaliplatin + 5-FU,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01075,,Oxaliplatin + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01079,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01079,,Cisplatin,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01079,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01079,,Docetaxel,treatment,10.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01079,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01087,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01087,,Docetaxel,treatment,1.5 mg/kg,,,,partial response,,drugdosing,JAX
TM01087,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM01087,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01087,,Topotecan,treatment,2.0 mg/kg,,,,complete response,,drugdosing,JAX
TM01117,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01117,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01117,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01117,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01117,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01149,,CMC,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01149,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01149,,Dabrafenib,treatment,100.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01149,,Temozolomide,treatment,30.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01273,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01273,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01273,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01273,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01273,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01278,,Docetaxel,treatment,10.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01278,,Doxorubicin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01278,,Cyclophosphamide,treatment,40.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01278,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01278,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01353,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01353,,Cisplatin,treatment,2.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01353,,Gemcitabine,treatment,150.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01353,,Gemcitabine + Cisplatin,treatment,100.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01353,,Gemcitabine + Cisplatin,treatment,2.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01555,,Saline,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01555,,5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01555,,Gemcitabine,treatment,150.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01555,,Gemcitabine + 5-FU,treatment,150.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01555,,Gemcitabine + 5-FU,treatment,20.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01563,,Docetaxel,treatment,10.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM01563,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01563,,Cisplatin,treatment,2.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM01594,,Rapamycin,treatment,5.0 mg/kg,,,,progressive disease,,drugdosing,JAX
TM01594,,D5W,treatment,5.0 ml/kg,,,,progressive disease,,drugdosing,JAX
TM01594,,Avastin + Rapamycin,treatment,5.0 mg/kg,,,,partial response,,drugdosing,JAX
TM01594,,Avastin,treatment,5.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM01594,,Temozolomide,treatment,50.0 mg/kg,,,,stable disease,,drugdosing,JAX
TM01594,,Valproic acid,treatment,400.0 mg/kg,,,,progressive disease,,drugdosing,JAX
CRC1241LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1241LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0071LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0071LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0126LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0126LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0070LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0070LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0324LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0324LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0061LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0061LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0370LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0370LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1575LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1575LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0188LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0188LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0028LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0028LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0199LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0199LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1586LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1586LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0431LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0431LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0096LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0096LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0508LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0508LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0471LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0471LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0124LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0124LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0064LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0064LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0094LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0094LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1473LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1473LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1605LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1605LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0025LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0025LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0246LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0246LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0054LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0054LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0127LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0127LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0133LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0133LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0173LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0173LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1144LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1144LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1389LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1389LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0356LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0356LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0556LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0556LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1182LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1182LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1599LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1599LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0073LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0073LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0165LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0165LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0167LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0167LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0574LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0574LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0097LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0097LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0063LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0063LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0024LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0024LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0297LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0297LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1562LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1562LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0136LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0136LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0180LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0180LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0400LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0400LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0129LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0129LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0014LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0014LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0449LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0449LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1369LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1369LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0027LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0027LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0056LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0056LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0109LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0109LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0115LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0115LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0143LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0143LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0190LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0190LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0242LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0242LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0261LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0261LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0262LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0262LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0309LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0309LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0321LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0321LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0328LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0328LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0378LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0378LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0382LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0382LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0394LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0394LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0416LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0416LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0442LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0442LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0468LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0468LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0481LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0481LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0490LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0490LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0495LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0495LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0516LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0516LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0716LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0716LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0065LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0065LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0098LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0098LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0144LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0144LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0243LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0243LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0334LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0334LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0505LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0505LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0718LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0718LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1472LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1472LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0062LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0062LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0099LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0099LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0358LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0358LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0537LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0537LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1502LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1502LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0202LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0202LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0477LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0477LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0095LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0095LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0542LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0542LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0069LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0069LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0103LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0103LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0257LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0257LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0067LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0067LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0131LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0131LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1432LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1432LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0196LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0196LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0076LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0076LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0152LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0152LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0494LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0494LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0362LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0362LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0316LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0316LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1342LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1342LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0276LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0276LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0187LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0187LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0197LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0197LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0314LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0314LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0348LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0348LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0349LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0349LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0396LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0396LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0277LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0277LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0344LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0344LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0354LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0354LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0060LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0060LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0100LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0100LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0139LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0139LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0149LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0149LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0237LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0237LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0435LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0435LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0479LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0479LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0527LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0527LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1138LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1138LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0179LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0179LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0371LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0371LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0032LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0032LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0504LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0504LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1486LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1486LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0077LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0077LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0343LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0343LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0134LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0134LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0291LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0291LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0312LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0312LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0104LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0104LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0171LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0171LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0475LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0475LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0252LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0252LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0019LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0019LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0150LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0150LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0528LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0528LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1063LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1063LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0021LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0021LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0029LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0029LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0101LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0101LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0116LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0116LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0174LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0174LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0580LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0580LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1264LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1264LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1337LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1337LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0053LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0053LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0137LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0137LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0145LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0145LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0147LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0147LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0159LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0159LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0175LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0175LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0184LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0184LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0219LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0219LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0239LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0239LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0265LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0265LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0391LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0391LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0441LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0441LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0456LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0456LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0458LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0458LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0493LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0493LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0512LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0512LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0616LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0616LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1166LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1166LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1313LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1313LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1314LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1314LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1321LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1321LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0022LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0022LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0057LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0057LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0085LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0085LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0105LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0105LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0306LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0306LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0307LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0307LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0465LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0465LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0480LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0480LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1278LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1278LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1430LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1430LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1522LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1522LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0379LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0379LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0066LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0066LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0117LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0117LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0176LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0176LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0440LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0440LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0515LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0515LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0525LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0525LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0166LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0166LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0031LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0031LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0079LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0079LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0121LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0121LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0153LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0153LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0186LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0186LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0254LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0254LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0030LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0030LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0081LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0081LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0285LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0285LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0080LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0080LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0151LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0151LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0078LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0078LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0534LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0534LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0161LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0161LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0177LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0177LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0148LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0148LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1169LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1169LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1272LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC1272LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0772LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0772LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0102LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0102LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0146LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0146LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0327LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0327LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0484LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0484LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0536LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0536LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0112LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0112LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1306LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1306LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0055LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0055LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0125LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0125LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0734LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0734LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0018LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0018LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0198LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0198LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0680LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0680LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0185LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0185LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1303LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1303LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0058LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0058LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0330LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0330LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1561LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1561LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1648LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1648LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0082LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0082LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0113LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0113LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0419LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0419LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0264LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0264LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0118LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0118LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0743LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0743LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0488LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0488LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0068LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0068LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1331LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC1331LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0059LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0059LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0231LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0231LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0399LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0399LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0420LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0420LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0438LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0438LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0204LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0204LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0106LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0106LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0128LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0128LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1145LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1145LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1329LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1329LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1376LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1376LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1408LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1408LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1501LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1501LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1581LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1581LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0581LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0581LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0626LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0626LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0670LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0670LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0773LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0773LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1067LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1067LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1071LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1071LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1157LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1157LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0706LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0706LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0771LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0771LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC1146LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1146LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1445LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1445LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0729LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0729LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0753LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0753LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1360LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1360LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0404LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0404LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC1449LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1449LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0783LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0783LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0578LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0578LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1367LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1367LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1379LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1379LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1399LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1399LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0610LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0610LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0323LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0323LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1530LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC1530LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1072LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC1072LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0322LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
CRC0322LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,partial response,,drugdosing,IRCC-CRC
CRC0403LM,,"Erbitux, Cetuximab",,20 mg/Kg,,,,stable disease,,drugdosing,IRCC-CRC
CRC0403LM,,0.9% Solution of Sodium Chloride,,0 mg/Kg,,,,progressive disease,,drugdosing,IRCC-CRC
